Genomic Prostate Score good value for guiding treatment

Chang EM, et al. Cost Effectiveness of the Oncotype DX Genomic Prostate Score for Guiding Treatment Decisions in Patients With Early Stage Prostate Cancer. Urology : 21 Dec 2018. Available from: URL: http://doi.org/10.1016/j.urology.2018.12.016